Sentence examples for monitoring ctc from inspiring English sources

This would definitely be a quantum leap in technological development for monitoring CTC, the time of release of CTC in blood, and monitoring therapeutic efficacies.

Compared to waiting for secondary tumors to appear, monitoring CTC counts may give companies a shortcut for measuring whether an antimetastasis drug works.

The UNICEF Indicators for Monitoring CtC guide sheet could have been instructive, but it apparently has little meaning for the implementing partners, who are not educators.

In drug development, monitoring CTC kinetics may be used to identify the best drug candidates and reduce the timeline required for clinical trials.

Currently, the only FDA-cleared platform for CTC enumeration is the CellSearch® system (Veridex, Raritan, NJ, USA), and is used for monitoring CTC in patients with colorectal, breast, and prostate cancer.

Our data support a prognostic role and potential clinical utility of monitoring CTC in conjunction with standard surveillance strategies for the follow-up of patients with operable breast cancer.

Indeed, by monitoring CTCs the acquisition of the recurrent T790M-EGFR drug resistance mutation became evident and coincided with the development of clinically refractory disease [ 55].

The prognostic utility of monitoring CTCs during adjuvant tamoxifen therapy was also shown in patients with hormone receptor-positive tumors since failure of tamoxifen to eradicate CTCs was associated with shorter DFS and OS.

Given the extraordinary impact of trastuzumab (Herceptin), a humanized monoclonal antibody directed against HER-2, in both the metastatic and adjuvant settings, monitoring CTCs for HER-2 could have an enormous influence on the application of this therapy.

The clinical value of single-cell genomic methods will be in profiling scarce cancer cells in clinical samples, monitoring CTCs, and detecting rare clones that may be resistant to chemotherapy.

In summary, the future medical applications of single-cell sequencing will be in early detection, monitoring CTCs during treatment of metastatic patients, and measuring the genomic diversity of solid tumors.